Immunoprecise Antibodies Ltd (IPA) — Cash Flow Quality Index
Immunoprecise Antibodies Ltd (IPA) has a Cash Flow Quality Index of 0.11x as of October 2016. Operating cash flow of $11.17K is below net income of $101.16K, suggesting accrual-heavy earnings not yet converted to cash. Explore Immunoprecise Antibodies Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Immunoprecise Antibodies Ltd Cash Flow Quality Index (2006–2016)
Historical Cash Flow Quality Index for Immunoprecise Antibodies Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Immunoprecise Antibodies Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Immunoprecise Antibodies Ltd (2006–2016)
Year-by-year earnings quality comparison for Immunoprecise Antibodies Ltd. For live market cap and the full company financial profile, see Immunoprecise Antibodies Ltd (IPA) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | 1.88x | $284.09K | $151.03K | ▲ +380.3% |
| 2014 | -0.67x | $-46.60K | $69.44K | ▼ -1.0% |
| 2006 | -0.66x | $-110.59K | $166.48K | — |